Chinese robotics stocks mixed after Beijing half-marathon showcases humanoid tech

Chinese robotics stocks were mixed after Honor’s humanoid robot won three podium spots and finished a Beijing half-marathon in 50:26, highlighting rapid progress and rising competition in the sector. Suppliers tied to the robot, including Lingyi iTech Guangdong, Lens Technology, and AAC Technologies, rose 3%-4%, while Ubtech fell 3.6% and the Hang Seng China A robotics index slipped 0.2%. Manycore Tech surged about 51% after its Hong Kong listing last week, underscoring strong investor interest in AI and robotics names.

Analysis

The market is treating this as a company-specific robotics race result, but the bigger signal is that humanoid robotics is shifting from a “proof of concept” story to a platform war where adjacent component makers can benefit even when the eventual winner is not yet public. That usually favors the picks-and-shovels layer first: navigation, sensing, structural modules, and manufacturing/test equipment tend to re-rate before the platform companies can prove unit economics. The fact that early public enthusiasm is already rotating into suppliers suggests the trade is moving from narrative alpha to supply-chain alpha.

For HSAI, the read-through is less about this single competition and more about whether robotics OEMs can internalize sensing stacks over time. If humanoids become a volume market, buyers will pressure lidar pricing hard, and the winners will be those with automotive-scale manufacturing and software stickiness rather than pure hardware exposure. That creates a two-phase setup: near term, robotics adoption supports demand; medium term, margin compression becomes the dominant risk as platforms negotiate down component ASPs.

XPEV is a lower-conviction beneficiary because humanoid visibility can help re-rate the firm’s innovation optionality, but the equity is still likely to trade primarily on EV fundamentals and execution. The risk is that investors over-assign robotics as a new TAM while the cash burn and car-market competition remain the main valuation anchors. If management can show robotics is levered to shared manufacturing, perception stack, and autonomy software, the market may reward that as an embedded asset rather than a distraction.

The contrarian view is that the move in robotics names may be too fragmented to sustain: a single high-profile performance can boost sentiment, but not all enablers deserve the same multiple. The sharp relative strength in some suppliers likely reflects factor momentum more than durable earnings revision, so the best risk/reward may be fading the most expensive “robotics beta” while owning the highest-quality infrastructure winners.

Key Decisions for Investors

• Maintain a tactical long HSAI only on pullbacks: 1-3 month horizon, with the thesis that robotics adoption expands lidar volume near term; stop if OEMs publicly shift to lower-cost proprietary sensing stacks, which would cap the upside at roughly 10-15% from sentiment alone.
• Reduce or avoid chasing XPEV strength here: use any 1-2 week rally to trim, since robotics optionality is likely a narrative overlay rather than the core valuation driver; downside is limited, but upside from this catalyst alone looks modest versus EV execution risk.
• Go long selected robotics supply-chain beneficiaries versus headline robot platforms: prefer high-quality component makers over pure-play humanoid names, because pricing power should accrue first to enabling tech with repeatable industrial demand; time horizon 3-6 months.
• Pair trade: long robotics-enabler basket / short a basket of over-owned humanoid pure plays, aiming to capture multiple compression when investors differentiate durable earnings power from promotional hype; risk is a continued sentiment squeeze for 2-4 weeks.
• If entering HSAI, consider a call spread rather than stock: this preserves upside from a robotics adoption rerate while limiting drawdown if the market decides the competitive threat to lidar is a medium-term margin issue.